| Literature DB >> 36227838 |
Winnie Bikaako1, Patricia Kabahango2, Kenneth Mugabi3, Agnes Yawe1, Kisembo Stallon4, Elizabeth Kyewalabye2, Lillian Tukahirwa2, Dean Kusiimakwe2, Meghan Stanley5, Beth Miller6, Anthony Mugisha2, Marieke H Rosenbaum5, Hellen Amuguni5.
Abstract
This paper describes the institutional context that shapes the visibility and positioning of women along the Peste des Petits Ruminants (PPR) and Newcastle Disease (ND) vaccine value chains for Sembabule district of Uganda. It examines the institutional barriers and opportunities that affect women's empowerment derived from inclusion of women in the decision-making processes along the livestock vaccine value chain (LVVC) and that can support viable women-centered and owned enterprises, at the vaccine development, delivery, distribution and use level. Qualitative data analysis tools such as focus group discussions, focus meals, jar voices and key informant interviews were used. Using outcome mapping, a stakeholder analysis of the critical partners in the PPR and ND value chain was done involving the regulators, vaccine manufacturers, importers, distributors, agrovets, public and private veterinary service deliverers, local leaders, women groups, and farmers. The study concluded that training related to gender equality and livestock vaccines, infrastructural and technical support to the poultry and goat women and men farmers and other chain actors are inadequate in themselves to increase vaccine adoption and improve livestock productivity in Sembabule district. Strategies that promote gender-transformative collaborative efforts among the LVVC actors and build viable gender-transformed women groups and networks are critical to increase women's participation in and benefit from the livestock vaccine value chain.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36227838 PMCID: PMC9560069 DOI: 10.1371/journal.pone.0270518
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1A map of Uganda and Sembabule district.
Esri, USGS | Esri, HERE, Garmin, FAO, NOAA, USGS | Esri, Michael Bauer Research GmbH, Uganda Bureau of Statistics.
Tools used and sample size.
| Tools used | Nº of events | Nº of participants | |||
|---|---|---|---|---|---|
| Male | Female | Male and female (Mix) | Total | ||
| Stakeholder meetings | 2 | 35 | 20 | 0 | 55 |
| Focus groups | 20 | 80 | 134 | 0 | 214 |
| Key Informant Interviews | 20 | 11 | 9 | 0 | 20 |
| Focus Meals | 4 | 0 | 0 | 82 | 82 |
| Jar voices | 8 | 0 | 0 | 72 | 72 |
Fig 2A gender sensitive model for VVC analysis.
Cost of new castle disease vaccine.
| Vaccine pack (doses/vial) | Cost/vial (UGShs) | Cost/dose (UGShs) |
|---|---|---|
| 100 | 3,500 | 35 |
| 500 | 5,000 | 10 |
| 1,000 | 7,000–17,000 (depending on country of origin) | 7–17 (depending on country of origin) |
Source: Personal communication with a distributor.
Classification of organizations along the gender equality continuum using the GECT.
| Place on Gender Continuum | Type of Organization in Category | No. of Organizations |
|---|---|---|
|
| 0 | 0 |
|
| ||
|
| Agrovet/ veterinary pharmacies and shops | 4 |
|
| ||
|
| Government ministries, departments and agencies, veterinarians’ organizations, pharmaceutical companies [vaccine manufacturers, importers and distributors], research | 9 |
|
| ||
|
| Academia | 1 |
|
| ||
|
|
| |
Fig 3Regulation of veterinary, vaccines, animals, and animal health service providers in Uganda.
Fig 4Private sector-led ND vaccine value chain.
Fig 5Typical government-led PPR vaccine value chain.